Nov 16th, 2009 - Reuters
Related topics:
* Zetia trial results less damaging to Merck than expected
* Merck shares rise 2.7 pct; Abbott up 1.3 pct
* Trial results presented at AHA meeting in Orlando
(Updates with details, additional analyst comment)
BOSTON, Nov. 16 (Reuters) - Shares of Merck & Co Inc(MRK.N) rose 2.7 percent on Monday after results of a clinicaltrial of its cholesterol drug Zetia were not as negative assome analysts had expected.
Related stories:
Study Questions Utility Of Merck Cholesterol Drugs
Nov 18th, 2009 - Wall Street Journal
(Adds analyst reaction beginning in eighth paragraph and updated stock price.) A new study by health insurer UnitedHealth Group Inc. (UNH) concludes Merck & Co.'s...
Merck up as Zetia trial less damaging than feared
Nov 16th, 2009 - Reuters
BOSTON (Reuters) - Shares of Merck & Co Inc (MRK.N) rose more than 2 percent in early trading on Monday after results of a clinical trial of its cholesterol drug Zetia were not as negative as some analysts had expected.
Merck, Abbott Shares Muted Pre-Market On Study Results
Nov 16th, 2009 - Wall Street Journal
Merck & Co. (MRK) shares fell less than 1% in pre-market trading Monday after a new study showed its Zetia cholesterol drug was inferior to Abbott Laboratories' (ABT) Niaspan at clearing clogged arteries. Merck shares traded at $32.90 recently...
CORRECT: Niaspan Reverses Artery Narrowing Versus Zetia
Nov 15th, 2009 - CNNMoney
("UPDATE: Niaspan Reverses Artery Narrowing Versus Zetia," at XXXX GMT,misstated Niaspan's sales figure in the fourth paragraph. The correct versionfollows:) Of DOW JONES...
UPDATE 2-Niaspan tops Zetia in new setback for Merck drug
Nov 15th, 2009 - Reuters
* Niaspan leads to reduction in artery wall thickness * No meaningful change seen with Zetia * 5 times as many serious adverse events seen with Zetia * Journal editorials cite several limitations of study (Adds reaction...
Related videos from YouTube:
- Vytorin -- believe the cholesterol...What is missed here is that the basic thesis of statins (cholesterol lowering drugs) is wrong. Although cholesterol may be high in some individuals with heart disease, it is not the cause of the disease, it is the result ...
